Skip to main content

Table 1 Serum biochemical parameters post injection 13 weeks in female mice

From: Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates

Back to article page

Molecular Medicine

ISSN: 1528-3658